The number of studies on deep learning for medical diagnosis is expanding, and these systems are often claimed to outperform clinicians. However, only a few systems have shown medical efficacy. From this perspective, we examine a wide range of deep learning algorithms for the assessment of glioblastoma - a common brain tumor in older adults that is lethal. Surgery, chemotherapy, and radiation are the standard treatments for glioblastoma patients. The methylation status of the MGMT promoter, a specific genetic sequence found in the tumor, affects chemotherapy's effectiveness. MGMT promoter methylation improves chemotherapy response and survival in several cancers. MGMT promoter methylation is determined by a tumor tissue biopsy, which is then genetically tested. This lengthy and invasive procedure increases the risk of infection and other complications. Thus, researchers have used deep learning models to examine the tumor from brain MRI scans to determine the MGMT promoter's methylation state. We employ deep learning models and one of the largest public MRI datasets of 585 participants to predict the methylation status of the MGMT promoter in glioblastoma tumors using MRI scans. We test these models using Grad-CAM, occlusion sensitivity, feature visualizations, and training loss landscapes. Our results show no correlation between these two, indicating that external cohort data should be used to verify these models' performance to assure the accuracy and reliability of deep learning systems in cancer diagnosis.

We present a novel end-to-end framework for solving the Vehicle Routing Problem with stochastic demands (VRPSD) using Reinforcement Learning (RL). Our formulation incorporates the correlation between stochastic demands through other observable stochastic variables, thereby offering an experimental demonstration of the theoretical premise that non-i.i.d. stochastic demands provide opportunities for improved routing solutions. Our approach bridges the gap in the application of RL to VRPSD and consists of a parameterized stochastic policy optimized using a policy gradient algorithm to generate a sequence of actions that form the solution. Our model outperforms previous state-of-the-art metaheuristics and demonstrates robustness to changes in the environment, such as the supply type, vehicle capacity, correlation, and noise levels of demand. Moreover, the model can be easily retrained for different VRPSD scenarios by observing the reward signals and following feasibility constraints, making it highly flexible and scalable. These findings highlight the potential of RL to enhance the transportation efficiency and mitigate its environmental impact in stochastic routing problems. Our implementation is available online.

Cancer is one of the leading causes of death worldwide, and head and neck (H&N) cancer is amongst the most prevalent types. Positron emission tomography and computed tomography are used to detect, segment and quantify the tumor region. Clinically, tumor segmentation is extensively time-consuming and prone to error. Machine learning, and deep learning in particular, can assist to automate this process, yielding results as accurate as the results of a clinician. In this paper, we investigate a vision transformer-based method to automatically delineate H&N tumor, and compare its results to leading convolutional neural network (CNN)-based models. We use multi-modal data from CT and PET scans to perform the segmentation task. We show that a solution with a transformer-based model has the potential to achieve comparable results to CNN-based ones. With cross validation, the model achieves a mean dice similarity coefficient (DSC) of 0.736, mean precision of 0.766 and mean recall of 0.766. This is only 0.021 less than the 2020 competition winning model (cross validated in-house) in terms of the DSC score. On the testing set, the model performs similarly, with DSC of 0.736, precision of 0.773, and recall of 0.760, which is only 0.023 lower in DSC than the 2020 competition winning model. This work shows that cancer segmentation via transformer-based models is a promising research area to further explore.

When oncologists estimate cancer patient survival, they rely on multimodal data. Even though some multimodal deep learning methods have been proposed in the literature, the majority rely on having two or more independent networks that share knowledge at a later stage in the overall model. On the other hand, oncologists do not do this in their analysis but rather fuse the information in their brain from multiple sources such as medical images and patient history. This work proposes a deep learning method that mimics oncologists' analytical behavior when quantifying cancer and estimating patient survival. We propose TMSS, an end-to-end Transformer based Multimodal network for Segmentation and Survival prediction that leverages the superiority of transformers that lies in their abilities to handle different modalities. The model was trained and validated for segmentation and prognosis tasks on the training dataset from the HEad & NeCK TumOR segmentation and the outcome prediction in PET/CT images challenge (HECKTOR). We show that the proposed prognostic model significantly outperforms state-of-the-art methods with a concordance index of 0.763+/-0.14 while achieving a comparable dice score of 0.772+/-0.030 to a standalone segmentation model. The code is publicly available.